In order to retain patents and make record profits, Covid-19 drugmakers pressured Twitter to censor activists pushing for generic vaccines.
BioNTech, along with the German government, contacted Nina Morschhaeuser, a lobbyist for Twitter in Europe, over an imminent campaign targeting the pharmaceutical companies developing the COVID-19 vaccine.
The campaign they were concerned about was the launch of an international push to force the drug industry to share the intellectual property and patents associated with coronavirus vaccine development. Making the patents available, in turn, would allow countries across the world to swiftly manufacture generic vaccines and other low-cost therapeutics to deal with the ongoing pandemic.
Morschhaeuser flagged the corporate accounts of Pfizer, BioNTech, Moderna, and AstraZeneca for her colleagues to monitor and shield from activists.
Many pharmaceutical lobby groups made exaggerated claims about the danger of sharing vaccine technology. PhRMA, another drug industry lobby group, falsely claimed on Twitter that any effort to allow the creation of a generic Covid vaccine would result in placing all 4.4 million jobs supported by the entire American drug industry at risk.
CyberBeat is a grassroots initiative from a team of producers and subject matter experts, driven out of frustration at the lack of media coverage, responding to an urgent need to provide a clear, concise, informative and educational approach to the growing fields of Cybersecurity and Digital Privacy.
If you have a story of interest, a comment, a concern or if you'd just like to say Hi, please contact us
We couldn't do this without the support of our sponsors and contributors.